<<

MEETING REPORT

Probing cellular systems with

Rami N Hannoush

Chemical and genetic approaches are extensively used to probe living systems at the subcellular level and to advance therapeutic target discovery. The 2006 American Society for meeting highlighted the growing importance of approaches in cell biology research.

Overlooking one of the world’s finest natural harbors, the San Diego Convention Center played host to the 46th annual meeting of the American Society for Cell Biology (ASCB) on December 9–13, 2006. More than 6,000 sci- entists and over 3,500 presentations of scien- tific research spanned traditional cell biology topics and extended to include cell biology of diseases, biosensors and computational appli- cations in cell biology. The research presented below underscores the growing role chemical biology is playing in advancing cell biology and drug discovery (Fig. 1) and presents some of the main challenges currently facing chemi- cal and chemical biology research. The use of chemical genetic and activity-based assays was a common thread in many ASCB presentations. The goal of such techniques is to identify small that will allow to address a host of interesting questions in cell biology. In many cases, RNA interference (RNAi) approaches provided an important complement to these The 46th annual meeting of the American Society for Cell Biology was held in San Diego, California on small- approaches. Advances in cellu- December 9–13, 2006. lar imaging methods were also featured prom- inently at the meeting and comprise another area in which chemical biology is having an molecules that perturb and uncov- cells but not in normal cells is one route to effec- impact on the study of cellular processes. ering their targets. They set up a genome-wide tive new anticancer therapeutics. RNAi screen in HeLa H2B-GFP cells (cells stably The Vale lab (Howard Hughes Medical Navigating cell division space expressing histone 2B fused to green fluorescent Institute, University of California, San Target identification of small-molecule hits ) to search for that sensitize cells Francisco) performed a whole-genome RNAi remains the primary bottleneck in chemical to a high-affinity Eg5 (a motor protein also screen in Drosophila melanogaster S2 cells to genetic screens. The Mitchison lab (Harvard) known as kinesin-5) inhibitor that is a clinical search for novel genes that regulate the mitotic described RNAi as an alternative approach for candidate and that works by the same mecha- spindle assembly checkpoint. Using high- investigating the mechanisms of action of small nism as monastrol1 (1; Fig. 2). Their aim was to throughput imaging combined with automated identify proteins involved in the cellular response quantitative image analysis, they identified to kinesin-5 inhibition and to understand the ~220 genes that are involved in aligning chro- Rami N. Hannoush is in the Department reasons behind cell sensitization. The scope of mosomes at the metaphase plate, controlling of Protein Engineering, Genentech Inc., this work extends to anticancer drug discovery. spindle length or shape, localizing γ-tubulin, 1 DNA Way, South San Francisco, California New cell-division targets with improved thera- and generating . Of these genes, 94080, USA. peutic indices are scarce, and uncovering pro- 69 proved to be completely new—that is, e-mail: [email protected] teins that are required for cell division in they are unannotated genes with previously

NATURE CHEMICAL BIOLOGY VOLUME 3 NUMBER 3 MARCH 2007 131 MEETING REPORT

proteins directly and induces in RNAi and over 80% of cancer cell lines from a variety small-molecule of origins with no effects on normal screening fibroblasts and endothelial cells6. The use of Cellular imaging Cell division Smac-mimetic molecules should find appli- cations in studying IAP-dependent apoptosis signaling mechanisms and in developing new anticancer agents.

Extracellular Membrane Mapping membrane trafficking and matrix Chemical biology trafficking regulation signaling Presently, there is a need for chemical tools that will allow the study of membrane trafficking events with greater flexibility than is possible Tumor with genetic techniques. Because membrane Apoptosis angiogenesis trafficking is a highly dynamic process inside GTPase and cells, small molecules are very helpful in that lipid kinase they act on a time scale commensurate with signaling the timing of trafficking events. The Payne group (University of California, Los Angeles) conducted an elegant chemical synthetic Figure 1 Chemical biology topics featured at the ASCB meeting. lethality screen in to identify small mol- ecules that mimic phenotypes of deletions of subunits of the clathrin adaptor AP-1, an unknown functions. In a secondary , they nuclear levels and that are involved in regulat- important component in vesicle trafficking used GFP tagging to investigate the subcellu- ing many aspects of cancer development. The between the trans-Golgi network and endo- lar localization and dynamics of these genes. study of RhoGTPase signaling pathways would somes. These piperazinyl-based small mol- This study is a comprehensive survey of all the be greatly aided by the development of spe- ecules block traffic specifically between the proteins that contribute to spindle assembly cific small-molecule inhibitors that target the trans-Golgi network and and do in D. melanogaster. The results underscore proto-oncogenic exchange factors (RhoGEFs) not appear to perturb other membrane traf- the power of RNAi screens in revealing new that activate RhoGTPases. By using the Yeast ficking pathways. Because protein trafficking mitotic regulators and in identifying potential Exchange Assay method3, the Blangy group mechanisms are conserved between yeast and targets for cancer therapy. The complication (National Council for Scientific Research, humans, these molecules can be used to study in conducting these screens does not lie in the France) screened a 3,500-member chemical the mechanisms of clathrin-mediated protein compilation of gene lists but rather in char- compound library and identified a potential transport at the Golgi complex. acterizing the functions of novel gene hits to inhibitor of Trio-GEFD1, an exchange factor Lipid kinases have a significant role both in ensure specificity and uniqueness—a task that of the RhoGTPase RhoG. This small molecule normal signaling pathways such as the insu- was elegantly achieved by the Vale lab. seems to be specific to Trio-GEFD1 and hence lin pathway and in disease pathways such as To explore the utility of ‘privileged’ chemical is being pursued as a tool for dissecting the cancer. Phosphatidylinositol-3-OH kinase scaffolds, the Kapoor group (Rockefeller) car- complex mechanisms that control RhoGTPase (PI(3)K) is one of the key lipid signaling ried out a phenotypic cell-based screen with a activation4,5. These studies may also serve as a kinases, and it exists in three isoforms that small collection of ~100 diaminopyrimidines stepping stone into the development of drug- interact with five different adaptor proteins. (DAPs) to uncover small-molecule probes that like molecules for this challenging class of There is no biochemical specificity between target proteins involved in regulating mito- potential anticancer targets. the adaptors and the isoforms (overall there sis2. They identified compounds that induce Identifying small-molecule leads for drug are 15 interaction possibilities), and the kinase changes in spindle geometry, discovery was another important theme at ATP binding site is absolutely conserved positioning and mitotic index. One inhibitor, the ASCB meeting. With a set drug target among the different isoforms, which makes named DAP-81 (2; Fig. 2), induces monopolar in mind, the Wang group, in collaboration dissecting the biological roles of different mitotic spindles and targets Polo-like kinases with the Harran and De Brabander groups PI(3)K-adaptor interactions very challeng- in vitro. These inhibitors are being pursued as (University of Texas Southwestern Medical ing. Small molecules are ideal tools for this tools for revealing new insights into the differ- Center at Dallas), designed a small molecule system because they can be specific and fast- ent roles Polo-like kinases have during the cell (3; Fig. 2) that mimics the of Smac, acting, thereby achieving selectivity among the cycle, including their effects on a proapoptotic protein. Once Smac is released various PI(3)K isoforms. Using a traditional dynamics with high temporal control and on from mitochondria, it binds and masks the pharmacological approach, the Shokat group regulation of assembly and maintenance of activity of a family of inhibitor of apoptosis (University of California, San Francisco) bipolar mitotic spindles. (IAP) proteins in human cells, thereby pro- identified selective small-molecule inhibitors moting apoptosis. However, many cancer of the different PI(3)K isoforms as probes of Chemical dissection of intracellular cells survive by blocking the release of Smac lipid kinase signaling7–9. This chemical matrix signaling via elevated concentrations of antiapoptotic of small molecules was used to demonstrate RhoGTPases are molecular hubs that relay Bcl-2 and related proteins. Wang showed that the PI(3)Kα isoform (known as p110α) signaling cascades at the cytoplasmic and that the identified Smac mimetic binds IAP is responsible for mediating insulin-response

132 VOLUME 3 NUMBER 3 MARCH 2007 CHEMICAL BIOLOGY MEETING REPORT

NO2 signaling in cultured cells; the group also N found that perturbing its activity abolishes HO the effects of insulin treatment in vivo. HN N NH O

O Venturing outside the cell Remodeling of the (ECM) HN O HN O has an important role in numerous human dis- S N eases. Investigating the molecular factors that H regulate the mechanisms of ECM remodeling Monastrol (1) DAP-81 (2) is critical to our understanding of tumorigen- esis. Using a small-molecule approach, the H Whitman group (Harvard) set forth to identify N the target and mode of action of halofuginone N N O N (4; Fig. 2), a potent small-molecule regulator NH N of ECM gene expression. They synthesized O O N S halofuginone analogs in order to gain insight S N O O into their -activity relationships, N N HN O and then they immobilized halofuginone N N on a polymer for affinity purification. They N identified a complex of nuclear Smac mimetic (3) H remodeling factors as the interacting target of halofuginone and probed the domains involved in the interaction. These studies are an important step toward developing selective NH2 therapeutic agents against ECM disorders and O OH N N H will aid in exploring ECM biology. Cl N N One of the cutting-edge technologies that O N N O HN N is driving cell biology research to a new fron- Br N H tier is the ability to regiospecifically control Halofuginone (4) SU5416 (5) PP1 (6) the physical and chemical microenvironments of cells as a means to address key biological questions. Though many lithographic meth- Figure 2 Small molecules used for exploring biology and for therapeutic target discovery. Monastrol ods have been developed to control the spatial (1) inhibits the mitotic kinesin Eg5 (also known as kinesin-5 or KSP); DAP-81 (2) modulates Polo- relationships between adherent cells, most of like kinase activity in vitro; Smac mimetic (3) binds IAP and induces apoptosis in human cancer them cannot be used to redefine microenvi- cells via caspase activation; halofuginone (4) regulates extracellular matrix gene expression; SU5416 (5) inhibits vascular endothelial growth factor ; and PP1 (6) inhibits Src ronments in real time to confine developing tyrosine kinases. or motile cells. To address this issue, the Shear lab (University of Texas, Austin) used two- photon to microfabricate in two kinase inhibitors, SU5416 (5; an inhibitor of can examine interactions at multiple levels. The real time high-resolution matrices (less than the proangiogenic vascular endothelial growth Tsien group (Howard Hughes Medical Institute, 1 µm in feature dimensions) that are suit- factor receptor) and PP1 (6; an inhibitor of the University of California, San Diego) developed able for monitoring and develop- oncogenic Src tyrosine kinase), on tumor pro- a new method as a longer-range alternative to ment10,11. By manipulating the topographic gression (Fig. 2). Their data reveal that the for- fluorescence resonance transfer (FRET) and chemical microenvironment of cultured mer compound causes shrinkage of tumor cells for imaging larger protein complexes inside cells, they were able to confine actively motile and regression of tumor-induced vasculature cells. The method uses singlet oxygen cells such as Escherichia coli12, and they also whereas the latter mainly perturbs tumor cell to a GFP-based reporter and allows detection showed directed neurite outgrowth in situ. survival. The development of a zebrafish can- of tens of nanometers of spatial proximities (an These results illustrate the potential to trap cer model is an important step in illuminating improvement over the FRET method, which and manipulate cells of interest using three- tumor cell invasion and angiogenesis processes, detects up to 100 Å in donor-acceptor spatial dimensional microfabrication. because existing cancer models do not allow for separation). The Tsien group has also devel- In an effort to understand how human tumor such direct high-resolution visualization in vivo. oped a new zinc-based polyhistidine dye pair cell invasion and angiogenesis occur, the Klemke This model also has great potential to provide a (HisZiFit) that is orthogonal (that is, chemi- lab (University of California, San Diego) devel- cost-effective means for pharmacological testing cally complementary) to previously reported oped a tumor xenograft model in transgenic of the effects of small molecules on tumor cell tetracysteine biarsenicals13. They also reported zebrafish. By taking advantage of the optical growth and angiogenesis. on a method named TimeSTAMP (time- transparency of zebrafish tissue, the group specific tagging and age measurement of pro- used quantitative high-resolution multicolor Biosensor applications and new imaging teins), which relies on sudden pharmacological three-dimensional imaging to directly visual- technologies inhibition of a genetically fused cis-acting ize tumor growth, angiogenesis and invasion As interest grows in studying protein-protein protease to allow high-resolution retrospec- in real time at the subcellular level. Using this interactions in living cells, there is need for tive visualization of new synaptic protein syn- cancer model, the group studied the effects of new imaging tools and optical reporters that thesis under various stimulation conditions.

NATURE CHEMICAL BIOLOGY VOLUME 3 NUMBER 3 MARCH 2007 133 MEETING REPORT

Altogether, these developments should further that involve loss of cell-cell junctions upon powerful sense of optimism for the future of enable the use of chemical tools to enlighten hepatocyte growth factor stimulation and chemical biology. complex cell biology. subsequent scattering of cells in space. This The Danuser (Scripps Institute) and Hahn live-cell microscopy-based approach also COMPETING INTERESTS STATEMENT The author declares that he has no competing (University of North Carolina) labs joined enables screening of small molecules against financial interests. efforts to combine computational and mul- tumor metastasis and facilitates the evalua- 1. Mayer, T.U. et al. Science 286, 971–974 (1999). tiplex imaging approaches to uncover the tion of their effects on migration regulation 2. Peters, U., Cherian, J., Kim, J.H., Kwok, B.H. & spatiotemporal characteristics of RhoGTPase and cell-cell adhesion. Kapoor, T.M. Nat. Chem. Biol. 2, 618–626 (2006). signaling. Using this approach to reconstruct 3. De Toledo, M. et al. FEBS Lett. 480, 287–292 (2000). the timing of activation of the small GTPases Perspectives 4. Blangy, A. et al. Biol. Cell 98, 511–522 (2006). Rac1, RhoA and Cdc42 during cell protru- An overall unifying theme of the 2006 ASCB 5. Blangy, A. et al. J. Cell Sci. 113, 729–739 (2000). 6. Li, L. et al. Science 305, 1471–1474 (2004). sion, they found that RhoA activation occurs meeting was to promote interdisciplinary sci- 7. Knight, Z.A. et al. Cell 125, 733–747 (2006). simultaneously with protrusion initiation, ence and to encourage creativity and innova- 8. Fan, Q.W. et al. Cancer Cell 9, 341–349 (2006). whereas Cdc42 activation is delayed and is tion among scientists. The continual merging 9. Toth, B. et al. J. Biol. Chem. 281, 36369–36377 (2006). followed by Rac1 activation. The Danuser of distinct yet overlapping disciplines in 10. Kaehr, B. et al. Anal. Chem. 78, 3198–3202 lab also reported on a software package to chemistry and biology is driving progress (2006). be used in combination with phase-contrast in scientific discoveries. The ASCB meeting 11. Kaehr, B., Allen, R., Javier, D.J., Currie, J. & Shear, J.B. Proc. Natl. Acad. Sci. USA 101, 16104– imaging that allows for time-resolved quan- highlighted chemical biology approaches that 16108 (2004). titative analysis of the spatial dynamics of are being pursued in cutting-edge cell biology 12. Kaehr, B. & Shear, J.B. J. Am. Chem. Soc. (in the press). cell movement. This is especially useful for and drug discovery. The research presented 13. Griffin, B.A., Adams, S.R. & Tsien, R.Y. Science 281, studying in vitro cancer metastasis models at this meeting engendered in its attendees a 269–272 (1998).

134 VOLUME 3 NUMBER 3 MARCH 2007 NATURE CHEMICAL BIOLOGY